Obesity Hypoventilation Syndrome.

Obesity Hypoventilation Syndrome.
复制标题

DOI:
10.1007/s13665-015-0108-6
复制
发表时间:
2015-03-01
影响因子:
0.6
通讯作者:
Parthasarathy S
Parthasarathy S
中科院分区:
其他
文献类型:
--
作者:
Shetty S;Parthasarathy S

文献摘要

被引文献

相似文献

肥胖低通气综合征是病态肥胖的呼吸系统后果,其特征是睡眠和清醒时肺泡通气不足。该疾病涉及呼吸力学受损、通气驱动和睡眠呼吸障碍之间复杂的相互作用。早期诊断和治疗很重要,因为延迟治疗与显着的死亡率和发病率相关。可用的治疗方案包括无创气道正压通气 (PAP) 治疗和减肥。关于此类疗法有效性的长期数据有限。这篇综述概述了当前临床表现、诊断和管理策略的概念,以帮助识别和治疗肥胖通气不足综合征患者。
Obesity hypoventilation syndrome is a respiratory consequence of morbid obesity that is characterized by alveolar hypoventilation during sleep and wakefulness. The disorder involves a complex interaction between impaired respiratory mechanics, ventilatory drive and sleep-disordered breathing. Early diagnosis and treatment is important, because delay in treatment is associated with significant mortality and morbidity. Available treatment options include non-invasive positive airway pressure (PAP) therapies and weight loss. There is limited long-term data regarding the effectiveness of such therapies. This review outlines the current concepts of clinical presentation, diagnostic and management strategies to help identify and treat patients with obesity-hypoventilation syndromes.